ALK Executive Vice President and CFO Claus Steensen Sølje is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 14, 2026, at 3:20 p.m. EDT. The conference runs from September 14 to 16, and ALK representatives will be available for meetings. ALK-Abelló A/S is a Denmark-based specialty pharmaceutical company focused on allergy, developing, producing and marketing products for diagnosing and treating respiratory allergies and severe allergic reactions, including anaphylaxis, in children and adults. The company employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen under ALK B.